Publication Information (EuropePMC) | |
Title | The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening. |
PubMed ID | 34214236(Europe PMC) |
doi | 10.1111/bju.15535 |
Publication Date | Aug. 15, 2021 |
Journal | BJU Int |
Author(s) | Benafif S, Ni Raghallaigh H, McGrowder E, Saunders EJ, Brook MN, Saya S, Rageevakumar R, Wakerell S, James D, Chamberlain A, Taylor N, Hogben M, Benton B, D'Mello L, Myhill K, Mikropoulos C, Bowen-Perkins H, Rafi I, Ferris M, Beattie A, Kuganolipava S, Sevenoaks T, Bower J, Kumar P, Hazell S, deSouza NM, Antoniou A, Bancroft E, Kote-Jarai Z, Eeles R. |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS005205 (PRS130_Pca) |
PGP000726 | Benafif S et al. BJU Int (2021) |
Prostate cancer | prostate carcinoma | 130 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005205/ScoringFiles/PGS005205.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM022572 | PGS005205 (PRS130_Pca) |
PSS012021| European Ancestry| 297 individuals |
PGP000726 | Benafif S et al. BJU Int (2021) |
Reported Trait: prostate cancer | — | — | Percentage of screened individuals diagnosed with cancer: 38.9 % | — | Threshold (90th centile) = 11.15 |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS012021 | — | — | 297 individuals, 100.0 % Male samples |
— | European | — | BARCODE1 | — |